
Join to View Full Profile
4646 N Marine DrChicago, IL 60640
Dr. Buyukcelebi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kadir Buyukcelebi is an internal medicine specialist based in Chicago, IL. He completed his residency in internal medicine in 2026 at Louis A Weiss Memorial Hospital and graduated from Hacettepe University Medical School in 2017. Dr. Buyukcelebi has authored multiple publications, with work featured in renowned journals such as Nature Communications and Biochemical Pharmacology. His research has primarily focused on leiomyoma genetics, engineered MED12 mutations, and vascular changes in hypertensive conditions.
Education & Training
- Louis A Weiss Memorial HospitalResidency, Internal Medicine, 2026
- Hacettepe University Medical SchoolClass of 2017
Certifications & Licensure
- IL State Medical License 2023 - 2026
Publications & Presentations
PubMed
- Therapeutic targeting of the tryptophan-kynurenine-aryl hydrocarbon receptor pathway with apigenin in MED12-mutant leiomyoma cells.Takashi Iizuka, Azna Zuberi, Helen Wei, John S Coon V, Melania Lidia Anton
Cancer Gene Therapy. 2025-04-01 - 3 citationsIntegrating leiomyoma genetics, epigenomics, and single-cell transcriptomics reveals causal genetic variants, genes, and cell types.Kadir Buyukcelebi, Alexander J Duval, Fatih Abdula, Hoda Elkafas, Fidan Seker-Polat
Nature Communications. 2024-02-07 - 9 citationsEngineered MED12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization.Kadir Buyukcelebi, Xintong Chen, Fatih Abdula, Hoda Elkafas, Alexander James Duval
Nature Communications. 2023-07-10
Research History
- Postdoctoral Research FellowCancer epigenetic and CRISPR-based genetic engineering.2020 - 2023
Other Languages
- Turkish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: